Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

Lignende værker

• Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.
  af: Reed, E, et al.
  Udgivet: (1986)
• Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.
  af: Poirier, M C, et al.
  Udgivet: (1985)
• Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
  af: Dabholkar, M, et al.
  Udgivet: (1994)
• Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
  af: Dimitra T Stefanou, et al.
  Udgivet: (2015-01-01)
• Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
  af: Stefanou, Dimitra T., et al.
  Udgivet: (2015)